Literature DB >> 9894632

Rheumatologic features of hematologic disorders.

M Ehrenfeld1, H Gur, Y Shoenfeld.   

Abstract

This review focuses on the various rheumatologic manifestations of hematologic diseases and is based on the English literature published over the past year. Interrelationships between leukemia, lymphoma, POEMS syndrome, multiple myeloma, hemophilia, and rheumatic manifestations are discussed. Other less common associated conditions dealt with include the RS3PE syndrome, large granular lymphocyte syndrome, and interferon-related arthritis. Finally, therapeutic measures, such as bone marrow transplantation and the use of granulocyte colony-stimulating factor, are reviewed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9894632     DOI: 10.1097/00002281-199901000-00011

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  5 in total

Review 1.  [Rheumatic and hemato-/oncological disorders].

Authors:  M A Reuss-Borst
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

Review 2.  Rheumatologic manifestations of benign and malignant haematological disorders.

Authors:  Vinod Ravindran; Parameswaran Anoop
Journal:  Clin Rheumatol       Date:  2011-06-23       Impact factor: 2.980

3.  [Tibial pain and unilateral knee arthritis: Precursors of paraneoplastic arthropathy].

Authors:  U Lange; G Bachmann; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2011-06       Impact factor: 1.372

Review 4.  Hematological malignancies mimicking rheumatic syndromes: case series and review of the literature.

Authors:  Gil Bornstein; Nadav Furie; Nimrod Perel; Ilan Ben-Zvi; Chagai Grossman
Journal:  Rheumatol Int       Date:  2018-07-18       Impact factor: 3.580

5.  Musculoskeletal manifestations in patients with malignant disease.

Authors:  Tamer A Gheita; Yasser Ezzat; Safaa Sayed; Ghada El-Mardenly; Waleed Hammam
Journal:  Clin Rheumatol       Date:  2009-11-08       Impact factor: 3.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.